Publication | Closed Access

First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells

Cell TherapyTransplantationHuman Ex VivoFirst-in-man Clinical ResultsT-regulatory CellImmunologyAutoimmunityT Cell ImmunityCd4 T Cell ResponsesGraft SurvivalCell BiologyImmunotherapyMedicineCell TransplantationGraft RejectionRegulatory T Cell Biology